National Healthcare (NHC) Cost of Revenue (2010 - 2026)

National Healthcare (NHC) has 17 years of Cost of Revenue data on file, last reported at $91.2 million in Q1 2026.

• Quarterly Cost of Revenue fell 1.32% year-over-year to $91.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $376.0 million (up 11.76% YoY) and the FY2025 annual result came in at $377.2 million, up 17.37% from the prior year.
• Cost of Revenue declined to $91.2 million in Q1 2026, from $96.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $96.6 million in Q3 2025 to a low of $71.0 million in Q4 2023.
• A 5-year average of $80.4 million and a median of $77.4 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue retreated 3.5% — and 2025, when it grew 19.41%.
• Tracing NHC's Cost of Revenue over 5 years: stood at $71.1 million in 2022, then fell by 0.17% to $71.0 million in 2023, then climbed by 17.37% to $83.3 million in 2024, then grew by 15.49% to $96.2 million in 2025, then decreased by 5.16% to $91.2 million in 2026.
• The last three Cost of Revenue figures came in at $91.2 million (Q1 2026), $96.2 million (Q4 2025), and $96.6 million (Q3 2025), per Business Quant data.